Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease – (Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease, Published online: 2018-11-29; | doi:10.1038/s41433-018-0289-7)

29 November 2018

This news item is available to RCOphth members only, please log in below to access.